REVIEW
How has research in the past 5 years changed my clinical practice
Correspondence to:
Professor Anne Greenough, Deparment of Child Health, 4th Floor Golden Jubilee Wing, Kings College Hospital, London SE5 9RS, UK; anne.greenough{at}kcl.ac.uk
This article discusses how research in the past 5 years into management strategies influencing respiratory outcomes has changed (or not changed) the authors clinical practice. Changes include using inhaled nitric oxide but no longer systemic pulmonary vasodilators in term born infants with pulmonary hypertension. Use of postnatal steroids is now restricted to systemic administration in infants with severe respiratory failure and who are ventilator dependent beyond 2 weeks of age. Infants with bronchopulmonary dysplasia, unless they have pulmonary hypertension, are maintained at oxygen saturation levels of 90–92% rather than
95%. Supine sleeping is instituted in prematurely born infants without contraindications several weeks prior to neonatal discharge to reinforce to parents the importance of supine sleeping their baby at home. Further research is required to identify the optimal respiratory support strategy, particularly for very immature infants.
This article has been cited by other articles:
-
Bhandari, A., Bhandari, V.
(2009). Pitfalls, Problems, and Progress in Bronchopulmonary Dysplasia. Pediatrics
123: 1562-1573
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



